Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumeris enables health systems and physician groups to transition to value-based care models using its proprietary technology and services. Its solutions have driven measurable improvements in patient outcomes, cost savings, and high CMS star ratings for affiliated plans such as Essence Healthcare. In recent years, the company has managed over $13 billion in medical spend across more than 1.4 million patient lives nationwide. Clinical results include a consistent CMS five-star rating for Essence Healthcare’s Medicare Advantage plan since at least 2022. The company reports significant reductions in total cost of care—20–25% lower compared to market benchmarks—and improved quality metrics such as reduced preventable admissions and emergency department utilization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumeris.